PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19170989-0	2009	Thrombin generation and clot formation in methylene blue-treated plasma and cryoprecipitate.	Methylene Blue	42-56	coagulation factor II, thrombin	Homo sapiens	0-8	
19170989-1	2009	BACKGROUND: Methylene blue (MB) treatment of plasma is known to reduce the activity of clotting factors, but its effect on thrombin generation and clot formation is not well documented.	Methylene Blue	12-26	coagulation factor II, thrombin	Homo sapiens	123-131	
19170989-7	2009	CONCLUSIONS: It is concluded that MB treatment is associated with a reduction in the thrombin-generating capacity of plasma, but has very little effect on the strength of clot formation as assessed by thrombelastometry.	Methylene Blue	34-36	coagulation factor II, thrombin	Homo sapiens	85-93